Rockley Photonics expands footprint with five new agreements

Rockley Photonics, a photonics-based health monitoring and communications company, has expanded its footprint in the consumer market for its non-invasive VitalSpex biomarker sensing platform by signing new partnership agreements with five global consumer electronics (CE) manufacturers, including four of the world’s top-ten manufacturers of wrist-based wearables.

With these new partnerships, Rockley has now established strategic relationships with six of the top-ten largest manufacturers of smart watches and wristbands (based on volume as reported by IDC).

These multi-year partnerships will focus on evaluating and incorporating the next generation of non-invasive biomarker sensing in a range of consumer devices, including smart watches, wristbands, and other wearables. Rockley expects that these partnerships will create new opportunities for its VitalSpex sensing platform and help expand the future availability of real-time, non-invasive biomarker sensing for people around the globe.

Dr. Andrew Rickman, chief executive officer and founder of Rockley Photonics, said: “We are excited that so many major players in the wearable market have decided to work with Rockley to validate the use of our unique biomarker sensing technology in future products. These new partnerships continue to build momentum for our VitalSpex sensing platform. They represent a significant step toward expanding our ‘Powered by Rockley’ presence in consumer wearables, bringing us closer to our goal of giving people the timely insights needed to manage their health and wellbeing.”

The Rockley VitalSpex sensing platform is designed to enable device manufacturers to integrate more comprehensive non-invasive biomarker measurements in their products. By building its patented silicon photonics-based laser technology into a new generation of sensors, Rockley has significantly expanded the range of biomarkers that can be detected and measured non-invasively, extending far beyond the capabilities of current LED-based sensors. The expanded range of biomarkers includes core body temperature, blood pressure, body hydration, alcohol, lactate, and glucose trends. The new measurement capabilities have the potential to transform digital healthcare by providing real-time insights about a variety of health conditions and by enabling early detection of multiple disease states.

Rockley is currently conducting human studies to refine the performance of its end-to-end sensing solution.